Clinical Trial

A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital

Study acronym: ZSPPCI
Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
The Principal Investigator believes that the study protocol requires major amendments and a redesign, and therefore withdraws the registration.
Summary
This study is a registry-based cohort investigation, prospectively enrolling patients who were diagnosed with acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI) at Zhongshan Hospital, Fudan University, between January 1, 2009, and December 31, 2028. Baseline clinical characteristics, procedural details, laboratory results, and medication records will be systematically collected and documented. The clinical follow-up will encompass both in-hospital monitoring and post-discharge surveillance extending up to two years after the procedure.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Withdrawn 2026-08-05
critical Trial withdrawn: The Principal Investigator believes that the study protocol requires major amendments and a redesign, and therefore with... 2026-08-05
notable Enrollment reduced: 6000 -> 0 participants 2026-08-05
Trial Details
NCT Number NCT07400601
Lead Sponsor Shanghai Zhongshan Hospital
Conditions Acute Myocardial Infarction (AMI)
Start Date 2026-02-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-04